Hi-Tech’s dorzolamide ophthalmic solution is the generic for Merck’s Trusopt ophthalmic solution 2%, indicated for elevated intraocular pressure in patients with ocular hypertension or open-angel glaucoma. Hi-Tech said
Provectus is currently conducting Phase II clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and
In this position, Ms Perkins will continue to have responsibility for all of Infinity’s business functions, including corporate and product strategy, business development, finance, organizational development and human
The study is being conducted at clinical sites in the Netherlands and will enroll approximately 24 healthy subjects and six hepatitis C virus (HCV) infected patients. In this
New investor, HealthCare Ventures, led the round and Harold Werner, a partner with HealthCare Ventures, will join InfaCare’s board of directors. Additional funding came from new investor Longitude
The company said that 10 of 34 evaluable patients (29%) enrolled to date in the ongoing, single-arm, Simon two-stage design study evaluating the combination of Zybrestat and chemotherapy
This study showed that Orencia (abatacept) in combination with methotrexate (MTX) had significantly more patients achieve a disease activity score 28 using C-reactive protein [DAS28 (CRP)]-defined remission, compared
The Lilly color differentiation system – also used for Humalog and Humulin formulations marketed in Europe – follows the introduction of bar coding of packaging and insulin vials
Under the terms of this agreement, Shanghai Universal Biotech Company (SUBC) will become the exclusive distributor of Carna’s protein kinases within China. The agreement with SUBC makes these
Due to the long duration of response, patients only needed further treatment every two months, the company said. In addition, preliminary results of a Phase I/II study in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.